Edmond de Rothschild Holding’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Hold |
15,170
| – | – | ﹤0.01% | 408 |
|
|
2025
Q1 | $148K | Hold |
15,170
| – | – | ﹤0.01% | 402 |
|
|
2024
Q4 | $82.1K | Sell |
15,170
-4,000
| -21% | -$21.6K | ﹤0.01% | 464 |
|
|
2024
Q3 | $121K | Hold |
19,170
| – | – | ﹤0.01% | 458 |
|
|
2024
Q2 | $121K | Hold |
19,170
| – | – | ﹤0.01% | 470 |
|
|
2024
Q1 | $157K | Hold |
19,170
| – | – | ﹤0.01% | 442 |
|
|
2023
Q4 | $160K | Buy |
+19,170
| New | +$160K | ﹤0.01% | 452 |
|
|
2023
Q3 | – | Sell |
-22,820
| Closed | -$364K | – | 726 |
|
|
2023
Q2 | $364K | Sell |
22,820
-1,750
| -7% | -$27.9K | 0.01% | 399 |
|
|
2023
Q1 | $322K | Buy |
+24,570
| New | +$322K | 0.01% | 399 |
|